SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-018697
Filing Date
2024-05-10
Accepted
2024-05-10 17:15:25
Documents
17
Period of Report
2024-05-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 51296
2 ex1-1.htm EX-1.1 253839
3 ex5-1.htm EX-5.1 14159
4 ex5-1_001.jpg GRAPHIC 1974
  Complete submission text file 0001493152-24-018697.txt   556968

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE bmra-20240507.xsd EX-101.SCH 3018
6 XBRL LABEL FILE bmra-20240507_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE bmra-20240507_pre.xml EX-101.PRE 22361
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3554
Mailing Address 17571 VON KARMAN AVENUE IRVINE CA 92614
Business Address 17571 VON KARMAN AVENUE IRVINE CA 92614 9493792875
BIOMERICA INC (Filer) CIK: 0000073290 (see all company filings)

IRS No.: 952645573 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 001-37863 | Film No.: 24936009
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)